Relapsed Or Refractory Acute Leukaemia Or Myelodysplastic Syndromes With Hox Overexpression Genotypes clinical trials

Explore recruiting relapsed or refractory acute leukaemia or myelodysplastic syndromes with hox overexpression genotypes clinical trials.

Also recruiting in Europe

Relapsed Or Refractory Acute Leukaemia Or Myelodysplastic Syndromes With Hox Overexpression Genotypes trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Modular Phase I/II, Open-label, Multi-Centre Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants with Advanced Haematologic Malignancies with KMT2Ar, NPM1m, or Other Genotypes Associated with HOX Overexpression

Germany, Italy, Denmark

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Relapsed Or Refractory Acute Leukaemia Or Myelodysplastic Syndromes With Hox Overexpression Genotypes trials by city

Relapsed Or Refractory Acute Leukaemia Or Myelodysplastic Syndromes With Hox Overexpression Genotypes in Toronto Relapsed Or Refractory Acute Leukaemia Or Myelodysplastic Syndromes With Hox Overexpression Genotypes in Vancouver Relapsed Or Refractory Acute Leukaemia Or Myelodysplastic Syndromes With Hox Overexpression Genotypes in Montreal Relapsed Or Refractory Acute Leukaemia Or Myelodysplastic Syndromes With Hox Overexpression Genotypes in Calgary Relapsed Or Refractory Acute Leukaemia Or Myelodysplastic Syndromes With Hox Overexpression Genotypes in Edmonton Relapsed Or Refractory Acute Leukaemia Or Myelodysplastic Syndromes With Hox Overexpression Genotypes in Ottawa Relapsed Or Refractory Acute Leukaemia Or Myelodysplastic Syndromes With Hox Overexpression Genotypes in Winnipeg Relapsed Or Refractory Acute Leukaemia Or Myelodysplastic Syndromes With Hox Overexpression Genotypes in Quebec City Relapsed Or Refractory Acute Leukaemia Or Myelodysplastic Syndromes With Hox Overexpression Genotypes in Hamilton Relapsed Or Refractory Acute Leukaemia Or Myelodysplastic Syndromes With Hox Overexpression Genotypes in Kitchener Relapsed Or Refractory Acute Leukaemia Or Myelodysplastic Syndromes With Hox Overexpression Genotypes in London Relapsed Or Refractory Acute Leukaemia Or Myelodysplastic Syndromes With Hox Overexpression Genotypes in Halifax Relapsed Or Refractory Acute Leukaemia Or Myelodysplastic Syndromes With Hox Overexpression Genotypes in New York Relapsed Or Refractory Acute Leukaemia Or Myelodysplastic Syndromes With Hox Overexpression Genotypes in Los Angeles Relapsed Or Refractory Acute Leukaemia Or Myelodysplastic Syndromes With Hox Overexpression Genotypes in Chicago Relapsed Or Refractory Acute Leukaemia Or Myelodysplastic Syndromes With Hox Overexpression Genotypes in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease